https://globalresearchsyndicate.com/2019/11/22/critical-survey-aytu-bioscience-nasdaqaytu-versus-urovant-sciences-nasdaqurov/
Critical Survey: Aytu Bioscience (NASDAQ:AYTU) versus Urovant Sciences (NASDAQ:UROV) - Global...
Nov 22, 2019 - Aytu Bioscience (NASDAQ:AYTU) and Urovant Sciences (NASDAQ:UROV) are both small-cap medical companies, but which is the better business? We will
criticalsurveybiosciencenasdaqversus
https://www.fiercebiotech.com/biotech/urovant-seeks-150m-ipo-just-a-year-after-launch
Urovant seeks $150M IPO just a year after launch | Fierce Biotech
Jul 15, 2018 - Urovant Sciences came to life in June last year with a focus on urologic disorders and a phase 3 overactive bladder med licensed from Merck.
urovantseeksipo